Artificial Intelligence-Based Fluid Quantification in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treated with Faricimab A real-life Study

被引：0
|
作者：
Stanzel, Boris V. [1 ]
Messias, Andre Marcio [1 ]
Lorenz, Anna Theresa [1 ]
Darwisch, Warda [1 ]
Haring, Florian [1 ]
Roberts, Philipp K. [1 ]
Julich-Haertel, Henrike [1 ,2 ]
Boden, Karl Thomas [1 ]
Szurman, Peter [1 ,2 ]
机构：
[1] Knappschafts Klinikum Saar GmbH, Krankenhaus Sulzbach, Eye Clin Sulzbach, Sulzbach, Saarland, Germany
[2] Klaus Heimann Eye Res Inst, Sulzbach, Germany
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2024年 / 65卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5642
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
    Desideri, Lorenzo Ferro
    Traverso, Carlo Enrico
    Nicolo, Massimo
    Munk, Marion R.
    PHARMACEUTICS, 2023, 15 (05)
  • [2] Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Quah, Nicole Q. X.
    Javed, Khawaja Muhammad Ammar Ali
    Arbi, Lamees
    Hanumunthadu, Daren
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 1479 - 1490
  • [3] Artificial intelligence-based predictions in neovascular age-related macular degeneration
    Ferrara, Daniela
    Newton, Elizabeth M.
    Lee, Aaron Y.
    CURRENT OPINION IN OPHTHALMOLOGY, 2021, 32 (05) : 389 - 396
  • [4] Faricimab (Vabysmo) for Age-Related Macular Degeneration and Diabetic Macular Edema
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1646): : 45 - 46
  • [5] Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema
    Diack, Cheikh
    Avery, Robert L.
    Cheung, Chui Ming Gemmy
    Csaky, Karl G.
    Gibiansky, Leonid
    Jaminion, Felix
    Gibiansky, Ekaterina
    Sickert, Denise
    Stoilov, Ivo
    Cosson, Valerie
    Bogman, Katrijn
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2024, 13 (11):
  • [6] Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review
    Liberski, Slawomir
    Wichrowska, Malgorzata
    Kociecki, Jaroslaw
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [7] Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
    Hang, Abraham
    Ngo, Taylor
    Virk, Jaipreet Singh
    Moussa, Kareem
    Moshiri, Ala
    Emami-Naeini, Parisa
    Park, Susanna S.
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 3781 - 3789
  • [8] Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes
    Agostini, Hansjuergen
    Abreu, Francis
    Baumal, Caroline R.
    Chang, Dolly S.
    Csaky, Karl G.
    Demetriades, Anna M.
    Kodjikian, Laurent
    Lim, Jennifer I.
    Margaron, Philippe
    Mones, Jordi M.
    Peto, Tunde
    Ricci, Federico
    Rueth, Matthias
    Singh, Rishi P.
    Stoilov, Ivaylo
    Swaminathan, Balakumar
    Willis, Jeffrey R.
    Westenskow, Peter D.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (11) : 3437 - 3451
  • [9] Treatment Approaches for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Almony, Arghavan
    AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (06): : S81 - S89
  • [10] Disease Burden of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Almony, Arghavan
    AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (06): : S75 - S80
12345